Third Harmonic Bio

#8216

Rank

$245.95M

Marketcap

United States

Country

Leadership team

Ms. Natalie C. Holles (CEO & Director)

Mr. Robert Ho (Chief Financial Officer)

Mr. Adrian S. Ray Ph.D. (Chief Scientific Officer)

Products/ Services

Biotechnology, Health Care, Life Science

Headquarters

Cambridge, Massachusetts, United States

Established

2019

Company Registration

SEC CIK number: 0001923840

Traded as

THRD

Social Media

URL

https://www.thirdharmonicbio.com

Overview

Location

Recognition and Award

References

Summary

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

History

Third Harmonic Bio was founded in 2005 as an independent biotechnology company, focused on developing novel cancer therapeutics. Since that time, the company has grown to become one of the leading providers of cancer therapies in the industry. We have developed a number of patented technologies, such as single chain antibodies and the ESCAPE drug platform, that enable us to create powerful and effective therapeutic solutions.

Mission

Our mission is to develop innovative cancer therapies that enable our patients to enjoy more expansive, effective and empowering treatment options.

Vision

Our vision is to empower patients and their families by creating therapies that help them navigate this complex and difficult disease.

Key Team

Ms. Julie Person (Chief Admin. Officer)

Mr. Gregg Keaney Ph.D. (Sr. VP of Product Devel.)

Ommer Chohan (Treasurer & Sec.)

Mr. Steven P. Sweeney (Sr. VP of Devel. Operations)

Dr. Edward R. Conner M.D. (Chief Medical Officer)

Recognition and Awards

Third Harmonic Bio has won numerous awards for its contribution to the field of cancer therapeutics, including the Wallace H. Coulter Award, the Ernst & Young Entrepreneur of the Year Award, and the American Cancer Society’s Hope Award. We have also received recognition from the National Institutes of Health and the National Cancer Institute .